Your laboratory demands accurate, fast results in cardiac care. We offer comprehensive cardiac solutions that are a natural fit for laboratories. Our assays and analyzers provide accurate, reliable results with rapid turnaround time, aiding clinicians in providing better patient care.
For in vitro diagnostic use.
Leverage the power of Abbott's STAT High Sensitive Troponin-I to help more accurately identify in apparently healthy individuals who is at risk of a future cardiac event.
Gain confidence in results with excellent precision of our STAT High Sensitive Troponin-I assays.
To aid in diagnosis and assessment of severity of heart failure, Abbott provides a choice of heart failure tests offering both BNP and NT-proBNP biomarkers.
| Cardiac |
| Alere NT-proBNP |
| BNP |
| CK-MB |
| D-Dimer |
| Galectin-3 |
| Homocysteine |
| Myoglobin |
| STAT CK-MB |
| STAT High Sensitive Troponin-I |
| STAT Myoglobin |
Login or register for a new account on the Lab Central customer portal. Here you can view assay specific package inserts for intended use, important safety information and manage your personalized lab metrics.
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Receive exclusive benefits and resources when you register to access to the Customer Portal.
Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.
References:
1. Zheng Z, Croft JB, Giles WH, eta al. State-specific mortality from sudden cardiac death-United States, 1999. Morb Mortal Rep. 2002;52(06):123-6. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5106a3.htm.
2. Cardiovascular diseases (CVDs). World Health Organization. http://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(CVDs). Published May 2017. Accessed October 2018.
3. Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Surg. 2017;70(1):1-25. doi:10.1016/j.jacc.2017.04.052.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
